Dronedarone in high-risk permanent atrial fibrillation.
暂无分享,去创建一个
[1] D. Atar,et al. Dronedarone in high-risk permanent atrial fibrillation. , 2011, The New England journal of medicine.
[2] S. Nattel. Dronedarone in atrial fibrillation--Jekyll and Hyde? , 2011, The New England journal of medicine.
[3] J. Veale,et al. Kidney paired donation--the next step. , 2011, The New England journal of medicine.
[4] S. Connolly,et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.
[5] J. McMurray,et al. Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.
[6] H. Pollard,et al. Heart failure drug digitoxin induces calcium uptake into cells by forming transmembrane calcium channels , 2008, Proceedings of the National Academy of Sciences.
[7] H M James Hung,et al. Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials , 2007, Journal of biopharmaceutical statistics.
[8] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .
[9] Harlan M Krumholz,et al. Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.
[10] R. Falk,et al. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. , 2000, The American journal of cardiology.
[11] M. Di leo,et al. Transesophageal echocardiographic evidence of more pronounced left atrial stunning after chemical (propafenone) rather than electrical attempts at cardioversion from atrial fibrillation. , 1999, The American journal of cardiology.
[12] R. Falk,et al. Aggravation of postcardioversion atrial dysfunction by sotalol. , 1995, Journal of the American College of Cardiology.